We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




White-Matter Deficits Found in Codeine-Containing Cough Syrup Users

By LabMedica International staff writers
Posted on 01 Sep 2014
A magnetic resonance imaging (MRI) study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and linked these changes with increased impulsivity in codeine-containing cough syrup users. More...
These findings were consistent with findings from earlier research of heroin and cocaine addicts. White matter disruptions also correlated with the duration of CCS use.

Researchers used MR diffusion tensor imaging (DTI), combined with fractional anisotropy, to study the white matter integrity of chronic CCS users. Deficits were discovered in multiple regions of the brain, including the inferior fronto-occipital fasciculus, which other studies have found to be abnormal in other forms of addiction, such as addiction to the Internet, alcohol, and heroin.

The researchers, from the department of medical imaging of the First Affiliated Hospital of Gannan Medical University (Ganzhou, China), and the departments of medical imaging and interventional radiology, Cancer Center, Sun Yat-Sen University (Guangzhou, China), reported that the white matter deficits in CCS users also correlated with increased impulsivity characteristics in the study subjects, as measured by the Barratt impulsiveness scale. These findings were consistent with the findings of earlier studies of heroin and cocaine addicts. White matter disruptions also correlated with the duration of CCS use.

Codeine-containing cough syrups have become one of the most widespread drugs of abuse in young people worldwide. Progressive alterations in the white matter of users' brains may cause greater impulsivity in CCS users.

The study’s findings were published August 2014 on the website of the American Journal of Neuroradiology (AJNR).

Related Links:
Gannan Medical University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.